secwatch.observer — SEC 8-K summary
======================================

Issuer:     Syros Pharmaceuticals, Inc. (—)
CIK:        0001556263
Form:       8-K
Filed at:   2025-01-08T23:59:59+00:00
Accession:  0001193125-25-003483
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Syros receives Nasdaq deficiency notices for bid price, market value of listed securities, and publicly held shares
--------------------------------------------------------------------------------

- Bid price closed below $1.00 for 35 consecutive days; 180-day cure period until July 7, 2025.
- Minimum Value of Listed Securities (MVLS) below $50M for 30 consecutive business days.
- Market Value of Publicly Held Shares (MVPHS) below $15M for 35 consecutive business days.
- To regain compliance, stock must close at $1.00+ for 10 days; MVLS at $50M+; MVPHS at $15M+.
- May transfer to Nasdaq Capital Market or appeal delisting if non-compliance continues.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1556263/000119312525003483/0001193125-25-003483-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1556263/000119312525003483/d854734d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-003483

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer